Delivery Order SPE2DE21D0005-SPE2D625F0RYG
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,118.88 fixed-price delivery order to Organogenesis Inc. for PURAPLY AM (2X2) 4 SQ CM wound care dressing, with an ultimate completion date of September 29, 2025. The contract was awarded on September 23, 2025, without set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. The place of performance is the company's headquarters in Canton, Massachusetts. PURAPLY AM is an advanced...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $3,400 on July 17, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, which carries a fixed-price contract type with economic price adjustment provisions, is for PURAPLY AM XT EF, a 5-layer fenestrated advanced wound care product. The contract does not utilize a set-aside designation, indicating Organogenesis competed as a standard...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a $17.82K delivery order on September 9, 2025, for PURAPLY SX 6CM x 9CM wound care dressings. This fixed-price contract with economic price adjustment carries an ultimate completion date of September 12, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The award was made on a competitive basis with no set-aside designation, reflecting...
- The Defense Logistics Agency Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company. The order is for PURAPLY AM (2x2) 4 sq cm, a wound care dressing product. Organogenesis Inc. has provided a variety of surgical implants, wound care dressings, and tissue regeneration products to federal agencies like the Department of Veterans Affairs and the Defense Logistics Agency through multiple...
- This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs)...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a fixed-price delivery order contract with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company, to provide PURAPLY AM (2x2) 4 sq cm wound care dressings. The $1,678.32 contract has a completion date of January 10, 2024. Organogenesis Inc. has previously provided surgical implants, wound care dressings and matrices, tissue regeneration products, and other medical supplies to federal agencies...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D625F0RYGDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17.82K delivery order to Organogenesis Inc. on August 11, 2025, for PURAPLY SX 6CM X 9CM wound care products, with an ultimate completion date of August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. Performance will occur at the contractor's headquarters in Canton, Massachusetts. Organogenesis Inc. is a regenerative medicine company specializing in advanced wound care and surgical biologics, with a strong track record supplying medical products to federal healthcare agencies, particularly the Department of Veterans Affairs and Defense Logistics Agency. This delivery order likely derives from one of the company's significant standing Indefinite Delivery Vehicles, including a $49.5M multiple-award contract with DLA Troop Support Medical running through June 2026. PURAPLY products are advanced wound care dressings used for tissue regeneration and wound treatment, supporting critical medical care for military personnel and veterans across government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 8/11/25 |